sur INTEGRAGEN (EPA:ALINT)
IntegraGen: Revenue up despite loss of SeqOIA
IntegraGen announced a turnover of €4.5 million for the first half of 2024, recording a decrease of 20% compared to the same period in 2023. This decline results from the cessation of services for the SeqOIA platform, reducing revenue of €885k compared to €2.2m the previous year.
Excluding SeqOIA, other activities grew by 6%. Cash available at June 30, 2024 stood at €2.8 million, down by one million compared to the end of 2023. This decline is explained by variations in customer payment terms and the repayment of loans.
With a strengthened order book and obtaining CLIA certification, IntegraGen plans sustained growth. The Managing Director, Bernard Courtieu, highlights the efforts focused on high-margin activities and cost reduction measures to meet the current challenges.
R. H.
Copyright © 2024 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de INTEGRAGEN